Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) [Phase 2]
Phase 2 Lung-MAP trial evaluating the PARP inhibitor rucaparib in stage IV or recurrent non-small cell lung cancer patients with LOH-high tu…
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC [Phase 1, Phase 2]
A phase 1/2 trial evaluating carboplatin/nab-paclitaxel with pembrolizumab in non-small cell lung cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy [NA]
Clinical trial update for the STARS trial revising the protocol to evaluate SABR in stage I non-small cell lung cancer patients who can unde…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD [Phase 2]
Phase 2 trial evaluating pembrolizumab as first-line therapy for advanced non-small cell lung cancer complicated by COPD.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial [Phase 2]
Phase 2 multicenter trial evaluating first-line treatment for advanced non-small-cell lung cancer without driver gene alterations; status no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial assessed the safety of durvalumab given after sequential chemotherapy and radiation in unresectable stage III non-small c…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating hypofractionated radiotherapy alone in locally advanced non-small cell lung cancer was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 neoadjuvant study in early-stage non-small cell lung cancer comparing nivolumab plus ipilimumab or nivolumab plus chemotherapy versu…
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for BAY 59-8862 in treating patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation [Phase 2]
A Phase 2 trial evaluating first-line furmonertinib in advanced non-small cell lung cancer with EGFR uncommon mutations (G719X, L861Q, S768I…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients [Phase 3]
A Phase 3 trial comparing stereotactic body radiotherapy to conventional radiotherapy in medically inoperable non-small cell lung cancer pat…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy [Phase 2, Phase 3]
Phase 2/3 trial evaluating lung perfusion PET/CT using Ga68-MAA to preserve lung function during stereotactic body radiotherapy for lung can…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating Telaglenastat (CB-839) with Palbociclib in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC [Phase 2]
Phase 2 clinical trial update evaluating Envafolimab after ctDNA EGFR clearance by almonertinib in EGFR-mutant, PD-L1 positive non-small cel…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating SBRT with pembrolizumab, with or without avelumab/ipilimumab and dendritic cells, in solid tumors includin…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC [Phase 3]
Phase 3 trial comparing docetaxel plus plinabulin versus docetaxel plus placebo in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer [Phase 2]
Phase 2 trial updating Vopratelimab in combination with a CTLA-4 inhibitor in patients previously treated with PD-1/PD-L1 inhibitors (NSCLC …
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial assessing safety and efficacy of atezolizumab in previously treated locally advanced or metastatic non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of nivolumab with or without nab-paclitaxel in metastatic non-small cell lung cancer was terminated with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating Envafolimab plus Endostar/S-1 in second-line advanced non-small cell lung cancer, focusing on effect and saf…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC [Phase 2]
Phase 2 trial evaluating SBRT with a PD-1 inhibitor and thoracic hyperthermia for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection [Phase 2]
A multicenter Phase 2 clinical trial evaluating adjuvant icotinib in EGFR-mutant stage I non-small cell lung cancer at high risk of recurren…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations [Phase 2]
Phase 2 clinical trial evaluating osimertinib plus bevacizumab and chemotherapy for EGFR+ advanced non-small cell lung cancer with concurren…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating ensartinib as neoadjuvant therapy for patients with ALK-positive resectable non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy [Phase 2]
Phase 2 study evaluating camrelizumab plus apatinib as consolidation therapy after chemoradiotherapy in locally advanced non-small cell lung…